Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial

[1]  M. V. van Zelm,et al.  A randomized dietary intervention to increase colonic and peripheral blood SCFAs modulates the blood B- and T-cell compartments in healthy humans , 2022, The American journal of clinical nutrition.

[2]  S. Juraschek,et al.  Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial , 2022, Journal of the American Heart Association.

[3]  A. El-Osta,et al.  Maternal diet and gut microbiota influence predisposition to cardiovascular disease in the offspring , 2022, bioRxiv.

[4]  C. K. Yao,et al.  Supplementing dietary fibres with a low FODMAP diet in irritable bowel syndrome: a randomized controlled crossover trial , 2021, Clinical Gastroenterology and Hepatology.

[5]  Chris I. Hunter,et al.  Reporting guidelines for human microbiome research: the STORMS checklist , 2021, Nature Medicine.

[6]  Gretchen A. Stevens,et al.  Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants , 2021, The Lancet.

[7]  M. Carrington,et al.  The Gut Microbiome of Heart Failure With Preserved Ejection Fraction , 2021, Journal of the American Heart Association.

[8]  B. Tang,et al.  Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration , 2021, Microbiome.

[9]  M. Carrington,et al.  Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways , 2021, medRxiv.

[10]  J. Muir,et al.  Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial , 2021, Trials.

[11]  T. Kuwahara,et al.  Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health , 2021, Gut microbes.

[12]  M. V. van Zelm,et al.  Delivery of Acetate to the Peripheral Blood after Consumption of Foods High in Short-Chain Fatty Acids. , 2020, Molecular nutrition & food research.

[13]  K. Whelan,et al.  Dietary fibre in gastrointestinal health and disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[14]  C. K. Yao,et al.  Effects of fiber intake on intestinal pH, transit, and predicted oral mesalamine delivery in patients with ulcerative colitis , 2020, Journal of gastroenterology and hepatology.

[15]  Dan J Stein,et al.  Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[16]  R. Valls,et al.  Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study , 2020, Scientific Reports.

[17]  G. Celano,et al.  The Controversial Role of Human Gut Lachnospiraceae , 2020, Microorganisms.

[18]  T. Spector,et al.  Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease , 2020, Circulation.

[19]  L. Lerman,et al.  Coronary artery disease is associated with an altered gut microbiome composition , 2020, PloS one.

[20]  Jianguo Xia,et al.  Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data , 2020, Nature Protocols.

[21]  G. Stergiou,et al.  May Measurement Month 2019 The Global Blood Pressure Screening Campaign of the International Society of Hypertension , 2020 .

[22]  C. Mackay,et al.  Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension. , 2019, Hypertension.

[23]  Francesco Asnicar,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[24]  L. T. Te Morenga,et al.  Carbohydrate quality and human health: a series of systematic reviews and meta-analyses , 2019, The Lancet.

[25]  M. Grandoch,et al.  Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage , 2018, Circulation.

[26]  M. V. van Zelm,et al.  Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders , 2018, Alimentary pharmacology & therapeutics.

[27]  C. Pepine,et al.  Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. , 2018, Clinical science.

[28]  D. Harrison,et al.  The immunology of hypertension , 2018, The Journal of experimental medicine.

[29]  C. Mackay,et al.  Beyond gut feelings: how the gut microbiota regulates blood pressure , 2018, Nature Reviews Cardiology.

[30]  James L. Richards,et al.  Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes , 2017, Nature Immunology.

[31]  A. El-Osta,et al.  High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.

[32]  J. Raes,et al.  Population-level analysis of gut microbiome variation , 2016, Science.

[33]  M. Biddle,et al.  A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.

[34]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[35]  C. Mackay,et al.  Diet, gut microbiota and immune responses , 2010, Nature Immunology.

[36]  B. Heran,et al.  Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. , 2008, The Cochrane database of systematic reviews.

[37]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[38]  L. Cobiac,et al.  Excretion of starch and esterified short-chain fatty acids by ileostomy subjects after the ingestion of acylated starches. , 2007, The American journal of clinical nutrition.

[39]  D. Topping,et al.  Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. , 2003, The Journal of nutrition.

[40]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[41]  C. Nutting,et al.  Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. , 1991, The American journal of physiology.

[42]  M. Mulvany,et al.  Short chain fatty acids dilate isolated human colonic resistance arteries. , 1990, Gut.

[43]  M Marmot,et al.  INTERSALT Study Findings Public Health and Medical Care Implications , 1989, Hypertension.